BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9722 related articles for article (PubMed ID: 18706273)

  • 21. Surveillance options for patients with uveal melanoma following definitive management.
    Francis JH; Patel SP; Gombos DS; Carvajal RD
    Am Soc Clin Oncol Educ Book; 2013; ():382-7. PubMed ID: 23714555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of uveal melanomas, guidelines for oncologists].
    Mathis T; Cassoux N; Tardy M; Piperno S; Gastaud L; Dendale R; Maschi C; Nguyen AM; Meyer L; Bonnin N; Baillif S; Tick S; Mouriaux F; Jaspart F; Dellis J; Rosier L; Desjardins L; Herault J; Caujolle JP; Thariat J
    Bull Cancer; 2018 Oct; 105(10):967-980. PubMed ID: 30217336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uveal melanoma: physiopathology and new in situ-specific therapies.
    Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic uveal melanoma: diagnosis and treatment. A literature review.
    De Croock L; Verbraeken H
    Bull Soc Belge Ophtalmol; 2002; (286):59-63. PubMed ID: 12564318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
    Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
    Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases.
    Jager MJ; Dogrusöz M; Woodman SE
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):179-185. PubMed ID: 28399339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for uveal melanoma metastasis. Literature review.
    Missotten GS; Keunen JE
    Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.
    Vasalaki M; Fabian ID; Reddy MA; Cohen VM; Sagoo MS
    Br Med Bull; 2017 Jan; 121(1):107-119. PubMed ID: 28069617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular melanoma: what's new?
    Leyvraz S; Keilholz U
    Curr Opin Oncol; 2012 Mar; 24(2):162-9. PubMed ID: 22234256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in uveal melanoma treatment.
    Álvarez-Rodríguez B; Latorre A; Posch C; Somoza Á
    Med Res Rev; 2017 Nov; 37(6):1350-1372. PubMed ID: 28759124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intraocular tumors in adults: uveal melanoma].
    Mueller AJ; Schaller UC; Klingenstein A; Nentwich MM
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):R29-47; quiz R48. PubMed ID: 20234976
    [No Abstract]   [Full Text] [Related]  

  • 33. Uveal melanoma: Current evidence on prognosis, treatment and potential developments.
    Gelmi MC; Jager MJ
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100060. PubMed ID: 38641203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal malignant melanoma. An ophthalmological or oncological disease?
    Overgaard J
    Acta Ophthalmol Scand; 1996 Aug; 74(4):313. PubMed ID: 8883542
    [No Abstract]   [Full Text] [Related]  

  • 35. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
    Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
    Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
    Yoshida M; Selvan S; McCue PA; DeAngelis T; Baserga R; Fujii A; Rui H; Mastrangelo MJ; Sato T
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):297-308. PubMed ID: 24354797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Approaches to the Systemic Management of Uveal Melanoma.
    Khan S; Carvajal RD
    Curr Oncol Rep; 2020 Jul; 22(10):104. PubMed ID: 32725406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of metastatic malignant uveal melanoma].
    Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
    Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 487.